Banafsheh Zeinali-Rafsanjani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Banafsheh Zeinali-Rafsanjani has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Mahdi Saeedi-Moghadam
Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
18 shared publications - Fariba Zarei
Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran
9 shared publications - Reza Jalli
Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
9 shared publications - Mohammad Amin Mosleh-Shirazi
Shiraz University of Medical Sciences
7 shared publications - Reza Faghihi
Nuclear Engineering Department, Shiraz University, Shiraz, Iran
7 shared publications Mahdi Saeedi-Moghadam
Medical Imaging Research Center Shiraz University of Medical Sciences Shiraz Iran sums.ac.ir
6 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (17) , 2744
Simultaneous Preoperative Prediction of Locally Advanced Breast Cancer, DCIS Component, and Multifocality Using Structured Mammographic Features and Gradient-Boosting Machine Learning
Background/Objectives: Accurate preoperative detection of locally advanced breast cancer is essential for neoadjuvant therapy planning. We developed and validated gradient-boosting models using structured BI-RADS mammographic features to simultaneously predict locally advanced breast cancer (LABC), DCIS component, and multifocality in a multi-center cohort. Methods: This retrospective study enrolled 2295 patients from three university-affiliated hospitals; features were coded according to BI-RADS. CatBoost and logistic regression models were built using stratified 60/20/20 splits, with performance assessed via bootstrap resampling, nested cross-validation, and sensitivity analyses. AUROC, AUPRC, Brier score, and calibration metrics assessed discrimination and clinical utility; a leakage audit and SHAP analysis supported interpretation. Results: CatBoost achieved an AUROC of 0.906 (95% CI: 0.876–0.932) for LABC. Because several top predictors overlap with the anatomical criteria defining this outcome, we repeated the analysis excluding them; the reduced model retained a mean AUROC of 0.739, indicating genuine predictive signal beyond the staging overlap. Net benefit was positive across all relevant thresholds, with calibration error of 0.053. DCIS prediction was highly accurate (AUROC 0.979; nested AUROC 0.9707), with no evidence of leakage. Multifocality prediction was more modest (AUROC 0.810), reflecting known limits of two-dimensional mammography. Sensitivity analyses confirmed stable performance across splits, training sizes, and class-weighting schemes. Conclusions: Structured mammographic features combined with gradient-boosting support clinically meaningful, though partly overlapping, risk stratification for LABC; once accounted for, the model still retains independent value. The DCIS model performed very well; multifocality prediction remains more limited, and external validation is needed before clinical use.
- 27 August 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (17) , 2744
Open AccessSimultaneous Preoperative Prediction of Locally Advanced Breast Cancer, DCIS Component, and Multifocality Using Structured Mammographic Features and Gradient-Boosting Machine Learning
Background/Objectives: Accurate preoperative detection of locally advanced breast cancer is essential for neoadjuvant therapy planning. We developed and validated gradient-boosting models using structured BI-RADS mammographic features to simultaneously predict locally advanced breast cancer (LABC), DCIS component, and multifocality in a multi-center cohort. Methods: This retrospective study enrolled 2295 patients from three university-affiliated hospitals; features were coded according to BI-RADS. CatBoost and logistic regression models were built using stratified 60/20/20 splits, with performance assessed via bootstrap resampling, nested cross-validation, and sensitivity analyses. AUROC, AUPRC, Brier score, and calibration metrics assessed discrimination and clinical utility; a leakage audit and SHAP analysis supported interpretation. Results: CatBoost achieved an AUROC of 0.906 (95% CI: 0.876–0.932) for LABC. Because several top predictors overlap with the anatomical criteria defining this outcome, we repeated the analysis excluding them; the reduced model retained a mean AUROC of 0.739, indicating genuine predictive signal beyond the staging overlap. Net benefit was positive across all relevant thresholds, with calibration error of 0.053. DCIS prediction was highly accurate (AUROC 0.979; nested AUROC 0.9707), with no evidence of leakage. Multifocality prediction was more modest (AUROC 0.810), reflecting known limits of two-dimensional mammography. Sensitivity analyses confirmed stable performance across splits, training sizes, and class-weighting schemes. Conclusions: Structured mammographic features combined with gradient-boosting support clinically meaningful, though partly overlapping, risk stratification for LABC; once accounted for, the model still retains independent value. The DCIS model performed very well; multifocality prediction remains more limited, and external validation is needed before clinical use.
- 13 February 2026
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 39 (5) , 658-663
Prevalence of sexual dysfunction in relapsing-remitting multiple sclerosis and its association with brain and cervical cord MRI findings
Sexual dysfunction (SD), a prevalent yet underreported complication in multiple sclerosis (MS), significantly impacts quality of life. This cross-sectional study at Imam Reza Clinic, Shiraz University of Medical Sciences, evaluated SD prevalence in 80 relapsing-remitting MS (RRMS) patients (65 females and 15 males; mean age 38.7 years) compared to 80 demographically matched controls (61 females and 19 males; mean age 39.1 years). SD was assessed using the Female Sexual Function Index (FSFI) for females and the International Index of Erectile Function (IIEF) for males, alongside brain-focused MRI to examine morphological changes. Female RRMS patients had significantly lower FSFI scores (mean 21.80, SD 7.13) than controls (mean 27.86, SD 4.83; p < .001). FSFI scores negatively correlated with cerebrospinal fluid volume (r = −0.297, p = .016), disease duration (r = −0.319, p = .010), fatigue (r = −0.412, p = .001), and depression (r = −0.387, p = .002). Male RRMS patients showed lower IIEF scores (mean 64.40, SD 8.77) compared to controls (mean 73.21, SD 2.84; p = .0012), with positive correlations between IIEF scores and insular cortex volume (r = 0.576, p = .025), cerebellar grey matter volume (r = 0.727, p = .002), and total grey matter volume (r = 0.846, p < .001). Multivariate regression identified MRI measurements, disease duration, and fatigue as independent SD predictors ( p < .05). The high SD prevalence in RRMS, with distinct sex-specific neuroimaging correlates, highlights the need for routine SD screening and tailored interventions in MS care to improve patient outcomes.
- 13 February 2026
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 39 (5) , 658-663
Prevalence of sexual dysfunction in relapsing-remitting multiple sclerosis and its association with brain and cervical cord MRI findings
Sexual dysfunction (SD), a prevalent yet underreported complication in multiple sclerosis (MS), significantly impacts quality of life. This cross-sectional study at Imam Reza Clinic, Shiraz University of Medical Sciences, evaluated SD prevalence in 80 relapsing-remitting MS (RRMS) patients (65 females and 15 males; mean age 38.7 years) compared to 80 demographically matched controls (61 females and 19 males; mean age 39.1 years). SD was assessed using the Female Sexual Function Index (FSFI) for females and the International Index of Erectile Function (IIEF) for males, alongside brain-focused MRI to examine morphological changes. Female RRMS patients had significantly lower FSFI scores (mean 21.80, SD 7.13) than controls (mean 27.86, SD 4.83; p < .001). FSFI scores negatively correlated with cerebrospinal fluid volume (r = −0.297, p = .016), disease duration (r = −0.319, p = .010), fatigue (r = −0.412, p = .001), and depression (r = −0.387, p = .002). Male RRMS patients showed lower IIEF scores (mean 64.40, SD 8.77) compared to controls (mean 73.21, SD 2.84; p = .0012), with positive correlations between IIEF scores and insular cortex volume (r = 0.576, p = .025), cerebellar grey matter volume (r = 0.727, p = .002), and total grey matter volume (r = 0.846, p < .001). Multivariate regression identified MRI measurements, disease duration, and fatigue as independent SD predictors ( p < .05). The high SD prevalence in RRMS, with distinct sex-specific neuroimaging correlates, highlights the need for routine SD screening and tailored interventions in MS care to improve patient outcomes.
- Open Access
- 1 January 2026
- Published by Wiley in Radiology Research and Practice
- Vol. 2026 (1)
Association Between Pulmonary Artery Diameter on CT and Clinical Outcomes in COVID‐19: A 1000‐Patient Retrospective Analysis
Background: We evaluated the association between main pulmonary artery (PA) diameter on chest CT and CT‐defined lung involvement, intensive care unit (ICU) hospitalization, and in‐hospital mortality in patients hospitalized with COVID‐19. Methods: This retrospective cohort included 1000 adults with PCR‐confirmed COVID‐19 treated at Namazi and Shahid Faghihi Hospitals in 2020. For each patient, the first routine noncontrast chest CT obtained after admission was analyzed, provided it had been performed within the first 72 h. Main PA diameter was measured manually on axial images proximal to the PA bifurcation. Associations with age, sex, CT severity, ICU hospitalization, and in‐hospital outcome were evaluated. Results: The mean age was 56 ± 17.7 years; 525 patients (52.5%) were men and 475 (47.5%) were women. Mean PA diameter was 27.07 ± 3.84 mm. Men had a larger mean PA diameter than women (27.40 ± 3.77 vs. 26.69 ± 3.88 mm; p = 0.004), and age showed a weak positive correlation with PA diameter ( r = 0.282, p < 0.001). PA diameter increased across CT severity categories and was greater among patients who died and among those hospitalized in the ICU (all p < 0.001). Conclusions: Larger PA diameter was associated with greater CT‐defined lung involvement, ICU hospitalization, and in‐hospital mortality. Because the analyses were unadjusted and observational, these findings do not establish independent or incremental prognostic value.
- 1 January 2026
- Published by Wiley in Radiology Research and Practice
- Vol. 2026 (1)
Open AccessAssociation Between Pulmonary Artery Diameter on CT and Clinical Outcomes in COVID‐19: A 1000‐Patient Retrospective Analysis
Background: We evaluated the association between main pulmonary artery (PA) diameter on chest CT and CT‐defined lung involvement, intensive care unit (ICU) hospitalization, and in‐hospital mortality in patients hospitalized with COVID‐19. Methods: This retrospective cohort included 1000 adults with PCR‐confirmed COVID‐19 treated at Namazi and Shahid Faghihi Hospitals in 2020. For each patient, the first routine noncontrast chest CT obtained after admission was analyzed, provided it had been performed within the first 72 h. Main PA diameter was measured manually on axial images proximal to the PA bifurcation. Associations with age, sex, CT severity, ICU hospitalization, and in‐hospital outcome were evaluated. Results: The mean age was 56 ± 17.7 years; 525 patients (52.5%) were men and 475 (47.5%) were women. Mean PA diameter was 27.07 ± 3.84 mm. Men had a larger mean PA diameter than women (27.40 ± 3.77 vs. 26.69 ± 3.88 mm; p = 0.004), and age showed a weak positive correlation with PA diameter ( r = 0.282, p < 0.001). PA diameter increased across CT severity categories and was greater among patients who died and among those hospitalized in the ICU (all p < 0.001). Conclusions: Larger PA diameter was associated with greater CT‐defined lung involvement, ICU hospitalization, and in‐hospital mortality. Because the analyses were unadjusted and observational, these findings do not establish independent or incremental prognostic value.
- Open Access
- 21 October 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-9
Unveiling basidiobolomycosis: key imaging features and clinical correlations
Background: Basidiobolomycosis is a fungal infection exhibiting a wide spectrum of clinical manifestations that frequently resemble abdominal malignancies or inflammatory conditions. This study elucidates the characteristic imaging features that can help make an accurate diagnosis. Methods: We examined pretreatment imaging studies (CT, MRI, ultrasound) of 32 histopathologically proven cases of basidiobolomycosis at a tertiary referral center between 2015 and 2021. Two radiologists, blind to the pathology results, scrutinized the lesions for localization, morphology, enhancement pattern, and ancillary findings. Results: The cohort (mean age 9.8 ± 13.8 years and 53% male) demonstrated three basic imaging patterns: (1) hepatic lesions (21.9%) appearing as heterogeneously enhancing masses with necrotic cores; (2) gastrointestinal involvement (18.8%) showing circumferential wall thickening chiefly affecting the ileocecal region; and (3) mesenteric masses (15.6%) with peripheral enhancement and central necrosis. Other findings included regional lymphadenopathy (31.3%) and obstructive uropathy. At first, the misdiagnosis rate was 78%, most frequently as malignancy (37.5%) or appendicitis (31.2%). The follow-up indicated that 90.6% were responsive to treatment. Conclusion: Basidiobolomycosis shows distinct imaging characteristics, especially necrotic hepatic masses, and segmental bowel wall thickening, which could help differentiate the condition from neoplasms or inflammatory diseases. These findings act as a compelling argument to always include fungal etiologies within the differential diagnosis in patients with pertinent imaging findings in endemic regions.
- 21 October 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-9
Open AccessUnveiling basidiobolomycosis: key imaging features and clinical correlations
Background: Basidiobolomycosis is a fungal infection exhibiting a wide spectrum of clinical manifestations that frequently resemble abdominal malignancies or inflammatory conditions. This study elucidates the characteristic imaging features that can help make an accurate diagnosis. Methods: We examined pretreatment imaging studies (CT, MRI, ultrasound) of 32 histopathologically proven cases of basidiobolomycosis at a tertiary referral center between 2015 and 2021. Two radiologists, blind to the pathology results, scrutinized the lesions for localization, morphology, enhancement pattern, and ancillary findings. Results: The cohort (mean age 9.8 ± 13.8 years and 53% male) demonstrated three basic imaging patterns: (1) hepatic lesions (21.9%) appearing as heterogeneously enhancing masses with necrotic cores; (2) gastrointestinal involvement (18.8%) showing circumferential wall thickening chiefly affecting the ileocecal region; and (3) mesenteric masses (15.6%) with peripheral enhancement and central necrosis. Other findings included regional lymphadenopathy (31.3%) and obstructive uropathy. At first, the misdiagnosis rate was 78%, most frequently as malignancy (37.5%) or appendicitis (31.2%). The follow-up indicated that 90.6% were responsive to treatment. Conclusion: Basidiobolomycosis shows distinct imaging characteristics, especially necrotic hepatic masses, and segmental bowel wall thickening, which could help differentiate the condition from neoplasms or inflammatory diseases. These findings act as a compelling argument to always include fungal etiologies within the differential diagnosis in patients with pertinent imaging findings in endemic regions.
- Open Access
- 12 September 2025
- Published by MDPI AG in Tomography
- Vol. 11 (9) , 105
Rethinking MRI Protocols for Pituitary Microadenomas: Prioritizing Non-Contrast Imaging for Safe Follow-Up
Introduction and Objectives: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has been used as a gold standard in diagnosing and following pituitary microadenomas. However, the use of gadolinium-based contrast agents (GBCAs) involves a potential risk of long-term retention in tissues and adverse reactions. This study aimed to evaluate the sensitivity of non-contrast MRI (T1W and T2W sequences) in follow-up imaging of pituitary microadenomas, attempting a comparison with DCE-MRI, assessing tumor stability over time. Materials and methods: We retrospectively reviewed 300 pituitary MRI scans between 2020 and 2024. Included were patients with confirmed microadenomas (≤10 mm). Non-contrast (T1W/T2W) and DCE-MRI sequences were analyzed by an experienced radiologist blinded to any clinical information. Detection rates and changes in tumor size were evaluated. Results: Detection rates for 79 microadenomas were 55.7% for T1W, 70.9% for T2W, and 88.6% for DCE-MRI. There was no significant tumor growth during the follow-up (mean size 4.80 ± 2.3 mm vs. 4.81 ± 2.4 mm, p > 0.5). Conclusions: While still more sensitive for the primary diagnosis, the non-contrast MRI was able to visualize the majority of detected microadenomas, and significant growth was ruled out, thus supporting the case to omit gadolinium from follow-up imaging in stable cases. This may translate to lower costs and decreased patient risk from contrast-related hazards.
- 12 September 2025
- Published by MDPI AG in Tomography
- Vol. 11 (9) , 105
Open AccessRethinking MRI Protocols for Pituitary Microadenomas: Prioritizing Non-Contrast Imaging for Safe Follow-Up
Introduction and Objectives: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has been used as a gold standard in diagnosing and following pituitary microadenomas. However, the use of gadolinium-based contrast agents (GBCAs) involves a potential risk of long-term retention in tissues and adverse reactions. This study aimed to evaluate the sensitivity of non-contrast MRI (T1W and T2W sequences) in follow-up imaging of pituitary microadenomas, attempting a comparison with DCE-MRI, assessing tumor stability over time. Materials and methods: We retrospectively reviewed 300 pituitary MRI scans between 2020 and 2024. Included were patients with confirmed microadenomas (≤10 mm). Non-contrast (T1W/T2W) and DCE-MRI sequences were analyzed by an experienced radiologist blinded to any clinical information. Detection rates and changes in tumor size were evaluated. Results: Detection rates for 79 microadenomas were 55.7% for T1W, 70.9% for T2W, and 88.6% for DCE-MRI. There was no significant tumor growth during the follow-up (mean size 4.80 ± 2.3 mm vs. 4.81 ± 2.4 mm, p > 0.5). Conclusions: While still more sensitive for the primary diagnosis, the non-contrast MRI was able to visualize the majority of detected microadenomas, and significant growth was ruled out, thus supporting the case to omit gadolinium from follow-up imaging in stable cases. This may translate to lower costs and decreased patient risk from contrast-related hazards.
- Open Access
- 11 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1154
Assessment of the Relationship between Pre-Existing Muscle Atrophy, Subcutaneous Fat Volume, and the Prognosis of COVID-19
Background: Coronavirus disease 2019 (COVID-19), with its rapid transmission and emergence, has become a major global public health concern. COVID-19 patients are at an increased risk of acute skeletal muscle loss and complications such as muscular weakness, depression, and anxiety. Furthermore, sarcopenia has been linked to COVID-19 vulnerability, hospitalization rates, and severity. This study aims to investigate the relationship between pre-existing sarcopenia, subcutaneous fat, and the prognosis of COVID-19. Methods: Patients over 18 with positive tests who had chest CT scans without underlying conditions were included in this cohort study. The ratio of muscle volume to the total body surface area was calculated. Patients were divided into four subgroups: outpatients, hospitalized, ICU admitted, and deceased. The initial muscle volume for each group was compared. Results: In total, 127 patients were included in the study, 63 (49%) of whom were male. The mean age of the patients was 51.8 ± 18.16 (from 23 to 87 years). In total, 27 patients (21.3%) were treated as outpatients, 49 patients (38.6%) were hospitalized, and 23 (18.1%) were admitted to the ICU. Twenty-eight patients (22%) died. The total muscle/surface area ratio was significantly associated with disease outcome and prognosis. The ratio was significantly lower in dead individuals (p = 0.017). Conclusions: Sarcopenia was discovered to be significantly associated with the severity of COVID-19 and a poor prognosis. Reducing the risk of severe COVID-19 is possible by identifying and managing sarcopenia-related risk factors.
- 11 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1154
Open AccessAssessment of the Relationship between Pre-Existing Muscle Atrophy, Subcutaneous Fat Volume, and the Prognosis of COVID-19
Background: Coronavirus disease 2019 (COVID-19), with its rapid transmission and emergence, has become a major global public health concern. COVID-19 patients are at an increased risk of acute skeletal muscle loss and complications such as muscular weakness, depression, and anxiety. Furthermore, sarcopenia has been linked to COVID-19 vulnerability, hospitalization rates, and severity. This study aims to investigate the relationship between pre-existing sarcopenia, subcutaneous fat, and the prognosis of COVID-19. Methods: Patients over 18 with positive tests who had chest CT scans without underlying conditions were included in this cohort study. The ratio of muscle volume to the total body surface area was calculated. Patients were divided into four subgroups: outpatients, hospitalized, ICU admitted, and deceased. The initial muscle volume for each group was compared. Results: In total, 127 patients were included in the study, 63 (49%) of whom were male. The mean age of the patients was 51.8 ± 18.16 (from 23 to 87 years). In total, 27 patients (21.3%) were treated as outpatients, 49 patients (38.6%) were hospitalized, and 23 (18.1%) were admitted to the ICU. Twenty-eight patients (22%) died. The total muscle/surface area ratio was significantly associated with disease outcome and prognosis. The ratio was significantly lower in dead individuals (p = 0.017). Conclusions: Sarcopenia was discovered to be significantly associated with the severity of COVID-19 and a poor prognosis. Reducing the risk of severe COVID-19 is possible by identifying and managing sarcopenia-related risk factors.
- Open Access
- 9 July 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1345008
Determining the frequency of thyroid involvement in chest CT scans of COVID-19 patients and its correlation with the severity of lung involvement and survival of patients in 2020
Introduction: This study aimed to determine the frequency of thyroid gland involvement in chest CT scans of patients with COVID-19 admitted to university-affiliated hospitals and assess its relationship with the severity of lung involvement and patient survival in 2020.Material and methods: In this retrospective cross-sectional study, 1000 PCR-positive patients with COVID-19 who were referred to University-affiliated Hospital in 2020 and had chest CT performed within 72 hours of admission to the hospital were examined. The data was collected by patient file information and CT findings recorded in the PACS system, including thyroid involvement, the severity of lung involvement, and findings related to the death and recovery of patients.Results: The mean age of the examined patients was 56 years. 525 people (52.5%) were men, and 475 (47.5%) were women. 14% had severe pulmonary involvement, and 9.3% had very severe involvement. Moreover, 15.9 percent of them had deceased. 19.7% had focal thyroid involvement, 14% had diffuse involvement, and 66.3% were healthy subjects. Male gender and older age showed a significant relationship with thyroid gland involvement. The severity of lung involvement, the death rate in patients, and hospitalization in ICU were also significantly related to thyroid gland involvement in patients with COVID.Discussion and conclusion: This study highlights the importance of considering thyroid-gland involvement in the comprehensive management of COVID-19 patients. Routine screening and monitoring of thyroid-function may facilitate earlier detection and appropriate management of thyroid-related complications, potentially improving clinical outcomes. This study suggests that in COVID-19 infection the monitoring of thyroid function is prudent, particularly in cases of more serious disease.
- 9 July 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1345008
Open AccessDetermining the frequency of thyroid involvement in chest CT scans of COVID-19 patients and its correlation with the severity of lung involvement and survival of patients in 2020
Introduction: This study aimed to determine the frequency of thyroid gland involvement in chest CT scans of patients with COVID-19 admitted to university-affiliated hospitals and assess its relationship with the severity of lung involvement and patient survival in 2020.Material and methods: In this retrospective cross-sectional study, 1000 PCR-positive patients with COVID-19 who were referred to University-affiliated Hospital in 2020 and had chest CT performed within 72 hours of admission to the hospital were examined. The data was collected by patient file information and CT findings recorded in the PACS system, including thyroid involvement, the severity of lung involvement, and findings related to the death and recovery of patients.Results: The mean age of the examined patients was 56 years. 525 people (52.5%) were men, and 475 (47.5%) were women. 14% had severe pulmonary involvement, and 9.3% had very severe involvement. Moreover, 15.9 percent of them had deceased. 19.7% had focal thyroid involvement, 14% had diffuse involvement, and 66.3% were healthy subjects. Male gender and older age showed a significant relationship with thyroid gland involvement. The severity of lung involvement, the death rate in patients, and hospitalization in ICU were also significantly related to thyroid gland involvement in patients with COVID.Discussion and conclusion: This study highlights the importance of considering thyroid-gland involvement in the comprehensive management of COVID-19 patients. Routine screening and monitoring of thyroid-function may facilitate earlier detection and appropriate management of thyroid-related complications, potentially improving clinical outcomes. This study suggests that in COVID-19 infection the monitoring of thyroid function is prudent, particularly in cases of more serious disease.
- 1 April 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (7) , 1261-1263
Superimposed Double Guide Wire Loop Technique for Percutaneous Neoureterocystostomy for Refractory Ureteral Occlusions and Disruptions
- 1 April 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (7) , 1261-1263
Superimposed Double Guide Wire Loop Technique for Percutaneous Neoureterocystostomy for Refractory Ureteral Occlusions and Disruptions
- Open Access
- 18 August 2022
- Published by Medknow in Journal of Medical Ultrasound
- Vol. 31 (2) , 107-111
Assessment of the Adherence of Radiologists in Reporting the Ovarian Cysts to the 2010 Society of Radiologists in Ultrasound Guidelines
Background: The objective of this study was to determine the adherence of radiologists to the guideline of the Society of Radiologists in Ultrasound (SRU)-2010 for the follow-up of ovarian cysts in patients during 2015–2016. Methods: The patients’ data, referring for transvaginal and pelvic ultrasonography, suffering from ovarian cyst were assessed in terms of menopause status, cyst size, and type, as well as follow-ups recommended by radiologist to assess the adherence of reports to SRU-2010. Results: Three hundred and sixty-four sonography reports were investigated. Seventy-seven percent of the reports had adhered to SRU-2010, 9.9% and 9.1% had under/overmanagement, and 4.1% was incomplete. 94.2% and 5.8% of cases were in pre/postmenopause status, respectively. The highest adherence belonged to cysts in size <1 cm, 1–3 cm, 5–7 cm. The highest adherence, over/undermanagement, and incomplete reports belonged to corpus luteum, hemorrhagic, dermoid cysts, and nodules without flow. The adherence of sonography reports to SRU-2010 for accidental ovarian cysts was 76.9%. Conclusion: The tendency for overmanagement of simple cysts in premenopausal women and the tendency for undermanagement in simple cysts and in postmenopausal women were higher, respectively. It is expected that more training of the guideline to radiologists will lead to the reduction of unnecessary follow-up, which in turn leads to reduced patient’s anxiety and cost of treatment.
- 18 August 2022
- Published by Medknow in Journal of Medical Ultrasound
- Vol. 31 (2) , 107-111
Open AccessAssessment of the Adherence of Radiologists in Reporting the Ovarian Cysts to the 2010 Society of Radiologists in Ultrasound Guidelines
Background: The objective of this study was to determine the adherence of radiologists to the guideline of the Society of Radiologists in Ultrasound (SRU)-2010 for the follow-up of ovarian cysts in patients during 2015–2016. Methods: The patients’ data, referring for transvaginal and pelvic ultrasonography, suffering from ovarian cyst were assessed in terms of menopause status, cyst size, and type, as well as follow-ups recommended by radiologist to assess the adherence of reports to SRU-2010. Results: Three hundred and sixty-four sonography reports were investigated. Seventy-seven percent of the reports had adhered to SRU-2010, 9.9% and 9.1% had under/overmanagement, and 4.1% was incomplete. 94.2% and 5.8% of cases were in pre/postmenopause status, respectively. The highest adherence belonged to cysts in size <1 cm, 1–3 cm, 5–7 cm. The highest adherence, over/undermanagement, and incomplete reports belonged to corpus luteum, hemorrhagic, dermoid cysts, and nodules without flow. The adherence of sonography reports to SRU-2010 for accidental ovarian cysts was 76.9%. Conclusion: The tendency for overmanagement of simple cysts in premenopausal women and the tendency for undermanagement in simple cysts and in postmenopausal women were higher, respectively. It is expected that more training of the guideline to radiologists will lead to the reduction of unnecessary follow-up, which in turn leads to reduced patient’s anxiety and cost of treatment.
- Open Access
- 5 August 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (10) , 3767-3769
A case of aqueductal obstruction by web with no sign except a headache
- 5 August 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (10) , 3767-3769
Open AccessA case of aqueductal obstruction by web with no sign except a headache